Patent · US Active

Homodetic cyclic peptides targeting alpha-4-beta-7 integrin

US11286281B2 · kind B2 · utility

0Cited by
11References
18Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 10, 2018
Grant dateMar 29, 2022
Priority date—
Expiry dateJul 22, 2038

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A50/30
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

There is described herein antagonists of α4β7 integrin, and more particularly cyclic peptide antagonists, such as compounds of formula (I).

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.